This insider cluster is routine and non-informative. The sales are small in dollar terms, tied to option exercises, and likely driven by tax obligations or diversification. No bearish read-through is warranted. Monitor for any material change in insider behavior (e.g., a C-suite member selling >5% of their stake without a corresponding option exercise).
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 10 $544.10entry
- T+1 · 5mo ago +0.24%α −1.46% · $545.40
- T+5 · 5mo ago +0.77%α −2.67% · $548.27
- T+20 · 4mo ago +1.54%α −2.08% · $552.48
- T+60 · 2mo ago −9.90%α −16.48% · $490.24
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three top insiders at United Therapeutics, the CEO, CFO, and General Counsel, executed a cluster of open-market sales totaling ~$1.76M over a 7-day window. All sales were part of a coordinated pattern of option exercises and same-day share dispositions, consistent with routine tax-related selling rather than a bearish signal. The total value represents ~0.008% of the company's $23.1B market cap, well below the materiality threshold.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 1,462 shares at ~$544.89 on June 8, netting ~$797K
- CFO James Edgemond sold 1,565 shares at ~$544.93 on June 8, netting ~$853K
- EVP Paul Mahon sold 200 shares at ~$539.76 on June 4, netting ~$108K
- All sales were preceded by same-day option exercises at $0 or $117.76–$146.03 strike prices
- Total open-market sales of ~$1.76M represent ~0.008% of UTHR's $23.1B market cap
- No open-market purchases were made by any insider during the window
Financial Impact
Total insider sales of ~$1.76M, or ~0.008% of market cap, trivial relative to company size
Risk Factors
- No material risk identified from this insider activity
- If future filings show a shift to larger, unplanned open-market sales by multiple C-suite members, that would warrant a reassessment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1781042793178 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers